bf/NASDAQ:SAGE_icon.jpeg

NASDAQ:SAGE

Sage Therapeutics

  • Stock

USD

Last Close

6.30

12/11 21:00

Market Cap

663.81M

Beta: 1.15

Volume Today

563.59K

Avg: 531.49K

PE Ratio

−2.29

PFCF: −2.65

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '13
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
net income
-18.28M
-
-33.81M
84.95%
-94.50M
179.48%
-158.99M
68.25%
-270.12M
69.90%
-372.88M
38.04%
-680.24M
82.43%
606.07M
189.10%
-457.89M
175.55%
-532.78M
16.36%
-541.49M
1.63%
depreciation and amortization
47K
-
51K
8.51%
115K
125.49%
281K
144.35%
531K
88.97%
1.14M
115.25%
2.28M
99.74%
2.63M
15.20%
4.18M
59.01%
1.12M
73.17%
1.39M
24.15%
deferred income tax
stock based compensation
61K
-
2.51M
4,018.03%
15.24M
506.69%
23.02M
51.05%
35.53M
54.36%
101.96M
186.94%
153.23M
50.28%
95.99M
37.35%
104.63M
9.00%
61.60M
41.12%
73.37M
19.10%
change in working capital
593K
-
4.08M
587.86%
7.25M
77.69%
17.48M
141.14%
15.18M
13.17%
19.21M
26.59%
6.66M
65.34%
-39.73M
696.71%
-18.51M
53.42%
5.67M
130.64%
-67.38M
1,288.22%
accounts receivables
-18.51M
-
4.85M
126.19%
-69.35M
1,531.06%
inventory
18.51M
-
-4.85M
126.19%
69.35M
1,531.06%
accounts payables
674K
-
441K
34.57%
2.69M
509.98%
7.80M
189.81%
-3.69M
147.37%
24.54M
764.61%
-18.78M
176.53%
-11.51M
38.72%
6.69M
158.11%
8.43M
26.07%
-8.49M
200.74%
other working capital
-81K
-
3.64M
4,591.36%
4.56M
25.29%
9.68M
112.42%
18.87M
94.89%
-5.33M
128.26%
25.44M
577.14%
-28.22M
210.92%
-6.69M
76.30%
-2.76M
58.71%
-58.89M
2,032.11%
other non cash items
64K
-
127K
98.44%
1.21M
853.54%
-470K
138.81%
-398K
15.32%
-10.11M
2,439.45%
-10.64M
5.27%
-688K
93.53%
-10.60M
1,439.97%
4.35M
141.09%
-6.47M
248.68%
net cash provided by operating activities
-17.52M
-
-27.04M
54.38%
-70.68M
161.37%
-118.68M
67.91%
-219.28M
84.77%
-260.67M
18.88%
-528.71M
102.83%
664.28M
225.64%
-378.18M
156.93%
-460.04M
21.64%
-540.59M
17.51%
investments in property plant and equipment
-3K
-
-128K
4,166.67%
-198K
54.69%
-1.42M
617.68%
-1.36M
4.29%
-2.86M
110.29%
-5.75M
101.08%
-345K
94.00%
-372K
7.83%
-937K
151.88%
-553K
40.98%
acquisitions net
137.41M
-
-443.03M
422.43%
1.00B
326.19%
-326.37M
132.57%
-442.91M
35.71%
purchases of investments
-259.09M
-
-244.40M
5.67%
-1.48B
507.34%
-1.31B
11.84%
-458.72M
64.95%
-1.99B
333.85%
-881.04M
55.73%
-594.67M
32.50%
sales maturities of investments
30.50M
-
261.23M
756.50%
974.76M
273.15%
1.17B
20.16%
901.75M
23.01%
988.08M
9.57%
1.21B
22.20%
1.04B
14.02%
other investing activites
-525K
-
-285K
45.71%
-137.41M
-
443.03M
422.43%
-1.00B
326.19%
326.37M
132.57%
442.91M
35.71%
net cash used for investing activites
-3K
-
-128K
4,166.67%
-198K
54.69%
-230.54M
116,334.34%
15.18M
106.58%
-512.46M
3,476.56%
-143.16M
72.06%
442.68M
409.23%
-1.00B
326.45%
325.43M
132.46%
442.91M
36.10%
debt repayment
-2.80M
-
-6.79M
142.12%
-5.74M
15.48%
-6.30M
9.76%
-6.97M
10.65%
common stock issued
51K
-
96.30M
188,713.73%
129.72M
34.71%
330.18M
154.53%
326.02M
1.26%
631.49M
93.69%
561.28M
11.12%
417.50M
25.62%
14.72M
96.47%
3.11M
78.85%
6.93M
122.61%
common stock repurchased
-2.17M
-
-1.39M
-
-43K
96.90%
dividends paid
-629K
-
-7.60M
-
-3.23M
57.50%
other financing activites
22.73M
-
50.58M
122.48%
146K
99.71%
807K
452.74%
15.79M
1,857.00%
27.86M
76.43%
51.95M
86.46%
16.05M
69.11%
13.33M
16.93%
9.53M
28.56%
6.07M
36.32%
net cash used provided by financing activities
22.78M
-
146.87M
544.65%
129.87M
11.58%
330.98M
154.86%
341.82M
3.27%
659.36M
92.90%
607.62M
7.85%
426.76M
29.77%
13.33M
96.88%
3.07M
76.98%
6.03M
96.32%
effect of forex changes on cash
540.59M
-
net change in cash
5.26M
-
119.70M
2,173.94%
58.99M
50.72%
-18.24M
130.92%
137.72M
855.20%
-113.77M
182.61%
-64.24M
43.54%
1.53B
2,487.57%
-1.37B
189.15%
-131.53M
90.38%
-91.64M
30.33%
cash at beginning of period
2.80M
-
8.07M
187.87%
127.77M
1,484.01%
186.75M
46.17%
168.52M
9.76%
307.08M
82.23%
193.31M
37.05%
129.07M
33.23%
1.66B
1,188.27%
295.50M
82.23%
163.97M
44.51%
cash at end of period
8.07M
-
127.77M
1,484.01%
186.75M
46.17%
168.52M
9.76%
306.24M
81.72%
193.31M
36.88%
129.07M
33.23%
1.66B
1,188.27%
295.50M
82.23%
163.97M
44.51%
72.32M
55.89%
operating cash flow
-17.52M
-
-27.04M
54.38%
-70.68M
161.37%
-118.68M
67.91%
-219.28M
84.77%
-260.67M
18.88%
-528.71M
102.83%
664.28M
225.64%
-378.18M
156.93%
-460.04M
21.64%
-540.59M
17.51%
capital expenditure
-3K
-
-128K
4,166.67%
-198K
54.69%
-1.42M
617.68%
-1.36M
4.29%
-2.86M
110.29%
-5.75M
101.08%
-345K
94.00%
-372K
7.83%
-937K
151.88%
-553K
40.98%
free cash flow
-17.52M
-
-27.17M
55.09%
-70.88M
160.87%
-120.10M
69.44%
-220.64M
83.71%
-263.53M
19.44%
-534.46M
102.81%
663.93M
224.23%
-378.55M
157.02%
-460.97M
21.77%
-541.14M
17.39%

All numbers in USD (except ratios and percentages)